Table 1.

Data collected at baseline and during the follow-up

Patient-related characteristics	Baseline examination	Follow-up after 3 months	Follow-up after 6 months	Follow-up after 12 months	Follow-up after 24, 36, 48, 60 months
Age	X
Sex	X
Place of residence	X	X	X	X	X
Nationality	X
Marital status	X
Education	X
Occupation	X	X	X	X	X
Smoking	X	X	X	X	X
Alcolhol consumption	X	x	x	x	x
Female health (pregnancy, childbirth…)	X	x	x	x	x
(Prior) diseases	X	X	X	X	X
Prior treatments	X
Family history of PE	X
Symptoms of PE	X
Start of PE symptoms	X
(Prior) medication	X	X	X	X	X
Vital signs at hospital admission	X
Physical activity	X	X	X	X	X
Treatment-related variables	X
Date and time starting treatment prior admission	X
Diagnostic procedures	X
Date and time of diagnosis	X
In-hospital treatment	X
In-hospital complications	X
Medication	X
Treatment (eg, thrombolysis)	x
Laboratory values	X
General parameters
Date and time of hospital admission	X
Date hospital discharge	X
Outcome parameters
Health-related quality of life		X	X	X	X
Mental health		X	X	X	X
Healthcare utilisation		X	X	X	X
Medication		X	X	X	X
Treatment (eg, CPAP)		X	X	X	X
Relapse		X	X	X	X
Bleeding complications		X	X	X	X
Chronic thromboembolic pulmonary hypertension		X	X	X	X
Dietary intake	X	X	X	X

CPAP, continuous positive airway pressure.